House passes fraud bill to keep executives associated with wrongdoing from future Medicare business

NewsGuard 100/100 Score
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)." The CBO said a few individuals would be affected by the law and that it would not have a "significant budgetary impact" (Pecquet, 9/22).

Health News Florida: The bill will "plug holes in the law that enable companies and executives to keep defrauding Medicare and Medicaid without serious penalties. … The bill, titled Strengthening Medicare Anti-Fraud Measures Act, addresses two gaps in existing law: Executives who preside over companies while they're committing health fraud are able to jump to another company, without suffering consequences. The bill would let OIG bar them from continuing to do business with federal health programs. … Companies that engage in fraud often set up shell companies to take the fall, shielding the parent company from any real penalty" (Gentry, 9/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Covid and Medicare payments spark remote patient monitoring boom